RFP
PTCT icon

Root Financial Partners’s PTC Therapeutics PTCT Stock Holding History

Root Financial Partners’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-157
Closed -$10.7K – 2481
2026
Q1 		$10.7K Buy
157
+23
+17% +$1.63K ﹤0.01% 1660
2025
Q4 		$10.2K Buy
134
+36
+37% +$2.62K ﹤0.01% 1484
2025
Q3 		$6.01K Buy
+98
New +$5.1K ﹤0.01% 1648

Other funds holding PTCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Root Financial Partners's PTCT Position: Q2 2026 in Review

Root Financial Partners sold out of PTC Therapeutics (PTCT) in Q2 2026, closing a stake of 157 shares — an estimated $10.7K sold.

Root Financial Partners first reported a position in PTCT in Q3 2025 and held it in 3 quarters. The position peaked at $10.7K in Q1 2026. 83 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Root Financial Partners reported no remaining PTC Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 157 PTC Therapeutics shares in Q2 2026, an estimated $10.7K.
  • Root Financial Partners first reported a position in PTC Therapeutics in Q3 2025 and held it in 3 quarters.
  • Root Financial Partners's PTC Therapeutics position peaked at $10.7K in Q1 2026.
  • 83 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.